- Home
- WHLRP vs OSRHW Comparison
WHLRP vs OSRHW Comparison
Compare WHLRP & OSRHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WHLRP | OSRHW |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 56 | 21 |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | WHLRP | OSRHW |
|---|---|---|
| Price | $7.07 | $0.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.9K | ★ 22.0K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.00 | $0.03 |
| 52 Week High | $7.46 | $0.08 |
Technical Indicators
Market Signals| Indicator | WHLRP | OSRHW |
|---|---|---|
| Relative Strength Index (RSI) | 61.27 | 44.74 |
| Support Level | $3.52 | $0.04 |
| Resistance Level | $7.46 | $0.07 |
| Average True Range (ATR) | 0.33 | 0.00 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 100.00 | 0.00 |
Price Performance
Historical ComparisonAbout WHLRP Wheeler Real Estate Investment Trust Inc. Class B Preferred Stock
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About OSRHW OSR Holdings Inc. Warrant
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.